Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors

Journal of Clinical Hypertension

Volumn 20, Issue 2, 2018, Pages 208-211

  Frieden, Thomas R ^a   Jaffe, Marc G ^a,b  

^a Vital Strategies   (United States)

^b KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALL CAUSE MORTALITY; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; COST CONTROL; COUNTRY ECONOMIC STATUS; DISEASE BURDEN; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; MORTALITY RATE; NOTE; PATIENT CARE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH; QUALITY OF LIFE; RISK REDUCTION; SODIUM INTAKE; THERAPY EFFECT; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; CARDIOVASCULAR DISEASE; COST OF ILLNESS; ECONOMICS; EVIDENCE BASED PRACTICE; GLOBAL HEALTH; MORTALITY; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PROCEDURES; RISK FACTOR;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; COST OF ILLNESS; EVIDENCE-BASED PRACTICE; GLOBAL HEALTH; HUMANS; HYPERTENSION; PATIENT CARE MANAGEMENT; PREVENTIVE HEALTH SERVICES; RISK FACTORS;

EID: 85042214174     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.13195     Document Type: Note

References (27)

1. Roth GA, Johnson C, Abajobir A, et al. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;71:1-25.
2. GBD 2013 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287-2323.
3. Gaziano TA, Bitton A, Anand S, Weinstein MC. International Society of Hypertension. The global cost of nonoptimal blood pressure. J Hypertens. 2009;27:1472-1477.
4. Stevens W, Peneva D, Li JZ, et al. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res. 2016;16:175.
5. Gaziano TA. Reducing the growing burden of cardiovascular disease in the developing world. Health Aff (Millwood). 2007;26:13-24.
6. Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441-450.
7. Padwal RS, Bienek A, McAlister FA, Campbell NR. Outcomes research task force of the Canadian hypertension education program. Epidemiology of hypertension in Canada: an update. Can J Cardiol. 2016;32:687-694.
8. Luepker RV, Steffen LM, Jacobs DR Jr, Zhou X, Blackburn H. Trends in blood pressure and hypertension detection, treatment, and control 1980 to 2009: the Minnesota Heart Survey. Circulation. 2012;126:1852-1857.
9. GSHTP Barbados Pilot Analysis Report, 2014-2016. Standardized Hypertension Treatment Project (SHTP). Healthy Caribbean Coalition, GSHTP Core Team and Professor Ian Hambleton, Chronic Disease Research Center. 2016.
10. Centers for Disease Control and Prevention (CDC). Achievements in public health, 1900-1999: decline in deaths from heart disease and stroke – United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:649-656.
11. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398.
12. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017. [Epub ahead of print]. https://doi.org/10.1016/j.jacc.2017.11.006.
13. Frieden TR, Bloomberg MR. Saving an additional 100 million lives. Lancet. 2017. [Epub ahead of print]. https://doi.org/10.1016/s0140-6736(17)32443-1.
14. SDGs. Sustainable Development Knowledge Platform. United Nations. https://sustainabledevelopment.un.org/sdgs.
15. Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the US by improvements in use of clinical preventive services. Am J Prev Med. 2010;38:600-609.
16. Angell SY, De Cock KM, Frieden TR. A public health approach to global management of hypertension. Lancet. 2015;385:825-827.
17. Ramsay LE. The hypertension detection and follow-up program: 17 years on. JAMA. 1997;277:167-170.
18. Frieden TR, King SM, Wright JS. Protocol-based treatment of hypertension: a critical step on the pathway to progress. JAMA. 2014;311:21-22.
19. Handler J. Commentary in support of a highly effective hypertension treatment algorithm. J Clin Hypertens (Greenwich). 2013;15:874-877.
20. World Health Organization. HEARTS: Technical Package for Cardiovascular Disease Management in Primary Health Care. Geneva, Switzerland: World Health Organization; 2016. http://www.who.int/cardiovascular_diseases/hearts/Hearts_package.pdf
21. Cobb LK, Anderson CA, Elliott P, et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 2014;129:1173-1186.
22. Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624-634.
23. Anderson CAM, Appel LJ, Okuda N, et al. Dietary sources of sodium in China, Japan, the United Kingdom, and the United States, women and men aged 40 to 59 years: the INTERMAP study. J Am Diet Assoc. 2010;110:736-745.
24. Beauchamp G, Bertino M, Engelman K. Failure to compensate decreased dietary sodium with increased table salt usage. JAMA. 1987;258:3275-3278.
25. He FJ, Pombo-Rodrigues S, Macgregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality. BMJ Open. 2014;4:e004549.
26. Noncommunicable Diseases: Campaign for Action – Meeting the NCD Targets. Geneva, Switzerland: World Health Organization; 2017. http://www.who.int/beat-ncds/en
27. World Health Organization. Global Hearts Initiative. Geneva, Switzerland: World Health Organization; 2017. http://www.who.int/cardiovasculardiseases/global-hearts/en